Fibrodysplasia ossificans progressiva : current concepts from bench to bedside
Heterotopic ossification (HO) is a disorder characterised by the formation of ectopic bone in soft tissue. Acquired HO typically occurs in response to trauma and is relatively common, yet its aetiology remains poorly understood. Genetic forms, by contrast, are very rare, but provide insights into th...
Saved in:
Main Authors: | , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/148375 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-148375 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-1483752023-03-05T16:46:14Z Fibrodysplasia ossificans progressiva : current concepts from bench to bedside Kaliya-Perumal, Arun-Kumar Carney, Tom J. Ingham, Philip William Lee Kong Chian School of Medicine (LKCMedicine) Institute of Molecular and Cell Biology, A*STAR Science::Medicine Bone Morphogenetic Protein ACVR1 Heterotopic ossification (HO) is a disorder characterised by the formation of ectopic bone in soft tissue. Acquired HO typically occurs in response to trauma and is relatively common, yet its aetiology remains poorly understood. Genetic forms, by contrast, are very rare, but provide insights into the mechanisms of HO pathobiology. Fibrodysplasia ossificans progressiva (FOP) is the most debilitating form of HO. All patients reported to date carry heterozygous gain-of-function mutations in the gene encoding activin A receptor type I (ACVR1). These mutations cause dysregulated bone morphogenetic protein (BMP) signalling, leading to HO at extraskeletal sites including, but not limited to, muscles, ligaments, tendons and fascia. Ever since the identification of the causative gene, developing a cure for FOP has been a focus of investigation, and studies have decoded the pathophysiology at the molecular and cellular levels, and explored novel management strategies. Based on the established role of BMP signalling throughout HO in FOP, therapeutic modalities that target multiple levels of the signalling cascade have been designed, and some drugs have entered clinical trials, holding out hope of a cure. A potential role of other signalling pathways that could influence the dysregulated BMP signalling and present alternative therapeutic targets remains a matter of debate. Here, we review the recent FOP literature, including pathophysiology, clinical aspects, animal models and current management strategies. We also consider how this research can inform our understanding of other types of HO and highlight some of the remaining knowledge gaps. Nanyang Technological University Published version A.-K.K.-P. is supported by a Nanyang Technological University (Lee Kong Chian School of Medicine) Research Scholarship. P.W.I. is supported by the Toh Kian Chui Foundation.. 2021-05-03T08:12:15Z 2021-05-03T08:12:15Z 2020 Journal Article Kaliya-Perumal, A., Carney, T. J. & Ingham, P. W. (2020). Fibrodysplasia ossificans progressiva : current concepts from bench to bedside. Disease Models & Mechanisms, 13(9). https://dx.doi.org/10.1242/dmm.046441 1754-8403 https://hdl.handle.net/10356/148375 10.1242/dmm.046441 32988985 9 13 en Disease Models & Mechanisms © 2020 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. application/pdf |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
Science::Medicine Bone Morphogenetic Protein ACVR1 |
spellingShingle |
Science::Medicine Bone Morphogenetic Protein ACVR1 Kaliya-Perumal, Arun-Kumar Carney, Tom J. Ingham, Philip William Fibrodysplasia ossificans progressiva : current concepts from bench to bedside |
description |
Heterotopic ossification (HO) is a disorder characterised by the formation of ectopic bone in soft tissue. Acquired HO typically occurs in response to trauma and is relatively common, yet its aetiology remains poorly understood. Genetic forms, by contrast, are very rare, but provide insights into the mechanisms of HO pathobiology. Fibrodysplasia ossificans progressiva (FOP) is the most debilitating form of HO. All patients reported to date carry heterozygous gain-of-function mutations in the gene encoding activin A receptor type I (ACVR1). These mutations cause dysregulated bone morphogenetic protein (BMP) signalling, leading to HO at extraskeletal sites including, but not limited to, muscles, ligaments, tendons and fascia. Ever since the identification of the causative gene, developing a cure for FOP has been a focus of investigation, and studies have decoded the pathophysiology at the molecular and cellular levels, and explored novel management strategies. Based on the established role of BMP signalling throughout HO in FOP, therapeutic modalities that target multiple levels of the signalling cascade have been designed, and some drugs have entered clinical trials, holding out hope of a cure. A potential role of other signalling pathways that could influence the dysregulated BMP signalling and present alternative therapeutic targets remains a matter of debate. Here, we review the recent FOP literature, including pathophysiology, clinical aspects, animal models and current management strategies. We also consider how this research can inform our understanding of other types of HO and highlight some of the remaining knowledge gaps. |
author2 |
Lee Kong Chian School of Medicine (LKCMedicine) |
author_facet |
Lee Kong Chian School of Medicine (LKCMedicine) Kaliya-Perumal, Arun-Kumar Carney, Tom J. Ingham, Philip William |
format |
Article |
author |
Kaliya-Perumal, Arun-Kumar Carney, Tom J. Ingham, Philip William |
author_sort |
Kaliya-Perumal, Arun-Kumar |
title |
Fibrodysplasia ossificans progressiva : current concepts from bench to bedside |
title_short |
Fibrodysplasia ossificans progressiva : current concepts from bench to bedside |
title_full |
Fibrodysplasia ossificans progressiva : current concepts from bench to bedside |
title_fullStr |
Fibrodysplasia ossificans progressiva : current concepts from bench to bedside |
title_full_unstemmed |
Fibrodysplasia ossificans progressiva : current concepts from bench to bedside |
title_sort |
fibrodysplasia ossificans progressiva : current concepts from bench to bedside |
publishDate |
2021 |
url |
https://hdl.handle.net/10356/148375 |
_version_ |
1759856153571885056 |